Saffron peptide fermentation microparticle structure

TWM688919UActive Publication Date: 2026-10-21恆陞生技股份有限公司
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115206890
Authority / Receiving Office
TW · TW
Patent Type
Utility models
Current Assignee / Owner
Filing Date
2026-07-21
Publication Date
2026-10-21
Estimated Expiration
2036-07-20

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

This invention provides a saffron peptide fermentation microparticle structure comprising: a core layer, which is a core entity formed by structuring saffron peptide fermentation product; a plurality of active particles dispersed within or on the surface of the core layer; a coating layer, which coats the outer periphery of the core layer; and a protective layer, which is disposed outside the coating layer and has a three-dimensional closed network structure. This layered configuration effectively stabilizes the activity of the saffron peptide fermentation product. Experiments have shown that this structure can significantly enhance the antioxidant capacity (AOC) of human retinal pigment epithelial cells by 19.7% and effectively reduce the inflammatory marker (TNF-α) by 26.9%, thus maintaining the health and stability of retinal cells.
Need to check novelty before this filing date? Find Prior Art

Claims

1. A saffron peptide fermentation microparticle structure, comprising: a core layer, which is a core entity formed by structuring saffron peptide fermentation product; a plurality of active particles dispersed in the interior or surface of the core layer; a coating layer covering the outer periphery of the core layer; and a protective layer disposed on the outer side of the coating layer, and having a three-dimensional closed network structure.

2. The saffron peptide fermentation microparticle structure as described in claim 1, which has the property of increasing antioxidant capacity (AOC) by 8.2% to 19.7% when applied to damaged eye cells.

3. The saffron peptide fermentation microparticle structure as described in claim 1, which has the property of reducing the inflammatory marker (TNF-α) by 21.5% to 26.9% when applied to inflamed ocular cells.